Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

Collaborator

Intervention

cabozantinib s-malate (1)

laboratory biomarker analysis (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

unresectable ewing sarcoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma Trial in France (Cabozantinib S-malate, Laboratory

Active, not recruiting

Metastatic Ewing Sarcoma
+9 more

Cabozantinib S-malate
Laboratory Biomarker Analysis

Bordeaux, France
+10 more

Nov 26, 2022